This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

SUSUMU INOUE, MD; YADDANAPUDI RAVINDRANATH, MBBS; JEANNE M. LUSHER, MD
Hematology Section Department of Pediatrics Children's Hospital of Michigan Wayne State University School of Medicine 3901 Beaubien Blvd Detroit, MI 48201

Am J Dis Child. 1982;136(2):175-176.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Sir.—We read with interest the article "Second Malignancy in Acute Lymphocytic Leukemia: Review of 33 Cases" by Drs Mosijczuk and Ruymann in the JOURNAL (1981;135:313-316). In the article the authors state, referring to four patients in whom chronic myelogenous leukemia (CML) developed after treatment of acute lymphocytic leukemia (ALL), that no patients had cytogenetic studies performed at the time of the initial diagnosis of ALL. We wish to point out that in a previous study,¹ quoted by Drs Mosijczuk and Ruymann, we did describe the cytogenetic data at the time of the occurrence of ALL in one of the patients (patient 4) the authors referred to. The karyotype of that initial marrow, as well as six subsequent consecutive remission marrows, were normal. The cytogenetic aspect on this patient was also separately published together with chromosome data from another two patients with juvenile CML.² Unlike adult-type CML with . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?